Article
Clinical relevance of Wilms tumor 1 gene mutations in childhood acute myeloid leukemia.
Blood - 4 Jun 2009
Hollink Iris H I M, van den Heuvel-Eibrink Marry M, Zimmermann Martin, Balgobind Brian V, Arentsen-Peters Susan T C J M, Alders Marielle, Willasch Andre, Kaspers Gertjan J L, Trka Jan, Baruchel Andre, de Graaf Siebold S N, Creutzig Ursula, Pieters Rob, Reinhardt Dirk, Zwaan C Michel
Abstract excerpt
Wilms tumor 1 (WT1) mutations have recently been identified in approximately 10% of adult acute myeloid leukemia (AML) with normal cytogenetics (CN-AML) and are associated with poor outcome. Using array-based comparative genome hybridization in pediatric CN-AML samples, we detected a WT1 deletion in one sample. The other WT1 allele was mutated. This prompted us to further investigate the role of WT1 aberrations...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
